Nicotine and lipopolysaccharide stimulate the production of MMPs and prostaglandin E2 by hypoxia-inducible factor-1α up-regulation in human periodontal ligament cells

Journal of Periodontal Research

Volumn 47, Issue 6, 2012, Pages 719-728

  Kim, Y S ^a   Shin, S I ^b   Kang, K L ^b   Chung, J H ^b   Herr, Y ^b   Bae, W J ^a   Kim, E C ^a  

^a School of Dentistry and Institute of Oral Biology   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

Hypoxia inducible factor 1 ; Lipopolysaccharide; MMPs; Nicotine; Periodontal ligament cells; Prostaglandin E2

Indexed keywords

CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINE; PROSTAGLANDIN E2;

ANALYSIS OF VARIANCE; ARTICLE; BIOSYNTHESIS; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; FIBROBLAST; HUMAN; METABOLISM; NONPARAMETRIC TEST; PERIODONTAL LIGAMENT; PHYSIOLOGY; PORPHYROMONAS GINGIVALIS; SIGNAL TRANSDUCTION; UPREGULATION;

ANALYSIS OF VARIANCE; CELL LINE, TRANSFORMED; CYCLOOXYGENASE 2; DINOPROSTONE; DRUG SYNERGISM; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIPOPOLYSACCHARIDES; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NICOTINE; PERIODONTAL LIGAMENT; PORPHYROMONAS GINGIVALIS; STATISTICS, NONPARAMETRIC; UP-REGULATION;

EID: 84867229554     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2012.01487.x     Document Type: Article

References (50)

1. Aznar C, Fitting C, Cavaillon JM. Lipopolysaccharide-induced production of cytokines by bone marrow-derived macrophages: dissociation between intracellular interleukin 1 production and interleukin 1 release. Cytokine 1990;2:259-265.
2. Agarwal S, Piesco NP, Johns LP, Riccelli AE. Differential expression of IL-1β, TNF-α, IL-6, and IL-8 in human monocytes in response to lipopolysaccharides from different microbes. J Dent Res 1995;74:1057-1065.
3. Kurtiş B, Tüter G, Serdar M, Pinar S, Demirel I, Toyman U. Gingival crevicular fluid prostaglandin E(2) and thiobarbituric acid reactive substance levels in smokers and non-smokers with chronic periodontitis following phase I periodontal therapy and adjunctive use of flurbiprofen. J Periodontol 2007;78:104-111.
4. Tsai CC, Hong YC, Chen CC, Wu YM. Measurement of prostaglandin E2 and leukotriene B4 in the gingival crevicular fluid. J Dent 1998;26:97-103.
5. Williams RC, Jeffcoat MK, Howell TH et al. Altering the progression of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen. J Periodontol 1989;60:485-490.
6. Birkedal-Hansen H, Moore WG, Bodden MK et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
7. Mäkelä M, Salo T, Uitto V-J, Larjava H. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. J Dent Res 1994;73:1397-1406.
8. Garlet GP, Cardoso CR, Silva TA et al. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol 2006;21:12-20.
9. Ingman T, Tervahartiala T, Ding Y et al. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol 1996;23:1127-1132.
10. Sorsa T, Tjäderhane L, Konttinen YT et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006;38:306-321.
11. Johnson GK, Guthmiller JM. The impact of cigarette smoking on periodontal disease and treatment. Periodontol 2000 2007;44:178-194.
12. McGuire JR, McQuade MJ, Rossmann JA et al. Cotinine in saliva and gingival crevicular fluid of smokers with periodontal disease. J Periodontol 1989;60:176-181.
13. Zhou J, Olson BL, Windsor LJ. Nicotine increases the collagen-degrading ability of human gingival fibroblasts. J Periodontal Res 2007;42:228-235.
14. Katono T, Kawato T, Tanabe N et al. Nicotine treatment induces expression of matrix metalloproteinases in human osteoblastic Saos-2 cells. Acta Biochim Biophys Sin 2006;38:874-882.
15. Lee HJ, Pi SH, Kim Y et al. Effects of nicotine on antioxidant defense enzymes and RANKL expression in human periodontal ligament cells. J Periodontol 2009;80:1281-1288.
16. Katono T, Kawato T, Tanabe N et al. Effects of nicotine and lipopolysaccharide on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in human osteoblasts. Arch Oral Biol 2009;54:146-155.
17. Tanaka H, Tanabe N, Shoji M et al. Nicotine and lipopolysaccharide stimulate the formation of osteoclast-like cells by increasing macrophage colony-stimulating factor and prostaglandin E2 production by osteoblasts. Life Sci 2006;78:1733-1740.
18. Shoji M, Tanabe N, Mitsui N et al. Lipopolysaccharide enhances the production of nicotine-induced prostaglandin E2 by an increase in cyclooxygenase-2 expression in osteoblasts. Acta Biochim Biophys Sin 2007;39:163-172.
19. Pi SH, Jeong GS, Oh HW et al. Heme oxygenase-1 mediates nicotine- and lipopolysaccharide-induced expression of cyclooxygenase-2 and inducible nitric oxide synthase in human periodontal ligament cells. J Periodontal Res 2010;45:177-183.
20. Semenza GL. Hypoxia-inducible factor 1, master regulator of O2 homeostasis. Curr Opin Genet Dev 1998;8:588-594.
21. Forsythe JA, Jiang BH, Iyer NV et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor-1. Mol Cell Biol 1996;16:4604-4613.
22. Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L. IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 2003;17:2115-2117.
23. Frede S, Stockmann C, Freitag P, Fandrey J. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB. Biochem J 2006;396:517-527.
24. Zhang Q, Tang X, Zhang ZF, Velikina R, Shi S, Le AD. Nicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways. Clin Cancer Res 2007;15:4686-4694.
25. Ng KT, Li JP, Ng KM, Tipoe GL, Leung WK, Fung ML. Expression of hypoxia-inducible factor-1α in human periodontal tissue. J Periodontol 2011;82:136-141.
26. Thornton RD, Lane P, Borghaei RC, Pease EA, Caro J, Mochan E. Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts. Biochem J 2000;350:307-312.
27. Kitagawa M, Kudo Y, Iizuka S et al. Effect of F-spondin on cementoblastic differentiation of human periodontal ligament cells. Biochem Biophys Res Commun 2006;349:1050-1056.
28. Lee SI, Kang KI, Shin SI, Heer Y, Lee YM, Kim EC. Endoplasmic reticulum stress modulates nicotine-induced extracellular matrix degradation in human periodontal ligament cells. J Periodontal Res 2012; PMID 224889671.
29. Henningfield J, Cohen C, Pickworth W. Psychopharmacology of nicotine. In: Lorleans T, Slade J, eds. Nicotine Addiction. Principles and Management. New York: Oxford University Press, 1993:24-45.
30. Tilashalski K, Rodu B, Mayfield C. Acessing the nicotine content of smokeless tobacco products. J Am Dent Assoc 1994;125:590-594.
31. Hoffmann D, Adams JD. Carcinogenic tobacco-specific N-nitrosamines in snuff and in the saliva of snuff dippers. Cancer Res 1981;41:4305-4308.
32. Benowitz NL. Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addition. N Engl J Med 1988;319:1318-1330.
33. Hillmann G, Dogan S, Geurtsen W. Histopathological investigation of gingival tissue from patients with rapidly progressive periodontitis. J Periodontol 1998;69:195-208.
34. Alpar B, Leyhausen G, Sapotnick A, Günay H, Geurtsen W. Nicotine-induced alterations in human primary periodontal ligament and gingiva fibroblast cultures. Clin Oral Invest 1998;2:40-46.
35. Dietrich T, Bernimoulin JP, Glynn RJ. The effect of cigarette smoking on gingival bleeding. J Periodontol 2004;75:16-22.
36. Chang YC, Huang FM, Tai KW, Yang LC, Chou MY. Mechanisms of cytotoxicity of nicotine in human periodontal ligament fibroblast cultures in vitro. J Periodontal Res 2002;37:279-285.
37. Kang SW, Park HJ, Ban JY, Chung JH, Chun GS, Cho JO. Effects of nicotine on apoptosis in human gingival fibroblasts. Arch Oral Biol 2011;56:1091-1097.
38. San Miguel SM, Opperman LA, Allen EP, Zielinski J, Svoboda KK. Antioxidants counteract nicotine and promote migration via RacGTP in oral fibroblast cells. J Periodontol 2010;81:1675-1690.
39. Fang Y, Svoboda KK. Nicotine inhibits myofibroblast differentiation in human gingival fibroblasts. J Cell Biochem 2005;95:1108-1119.
40. Wang PL, Ohura K. Porphyromonas gingivalis lipopolysaccharide signaling in gingival fibroblasts-CD14 and Toll-like receptors. Crit Rev Oral Biol Med 2002;13:132-142.
41. Clavel G, Valvason C, Yamaoka K et al. Relationship between angiogenesis and inflammation in experimental arthritis. Eur Cytokine Netw 2006;17:202-210.
42. Hollander AP, Corke KP, Freemont AJ, Lewis CE. Expression of hypoxia inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum 2001;44:1540-1544.
43. Nishikawa M, Yamaguchi Y, Yoshitake K, Saeki Y. Effects of TNF alpha and prostaglandin E2 on the expression of MMPs in human periodontal ligament fibroblasts. J Periodontal Res 2002;37:167-176.
44. Vardar-Sengul S, Buduneli E, Turkoglu O et al. The effects of selective COX-2 inhibitor/celecoxib and omega-3 fatty acid on matrix metalloproteinases, TIMP-1, and laminin-5gamma2-chain immunolocalization in experimental periodontitis. J Periodontol 2008;79:1934-1941.
45. Tipton DA, Flynn JC, Stein SH, Dabbous MKH. Cyclooxygenase-2 inhibitors decrease interleukin-1beta-stimulated prostaglandin E2 and IL-6 production by human gingival fibroblasts. J Periodontol 2003;74:1754-1763.
46. Alessi DR, James SR, Downes CP et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα. Curr Biol 1997;7:261-269.
47. Semenza GL. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 2002;64:993-998.
48. Bey P, Gorostizaga AB, Maloberti PM et al. Adrenocorticotropin induces mitogen-activated protein kinase phosphatase-1 in Y1 adrenocortical tumor cells. Endocrinology 2003;144:1399-1406.
49. Aeder SE, Martin PM, Soh JW, Hussaini IM. PKC-eta mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways. Oncogene 2004;23:9062-9069.
50. 2 and MMP-1 in human periodontal ligament cells. J Periodontal Res 2011;46:568-575.